Search

Search Constraints

You searched for: Author/Creator Vrablik, Michal

Search Results

2. A review of the evidence on reducing macrovascular risk in patients with atherogenic dyslipidaemia: A report from an expert consensus meeting on the role of fenofibrate–statin combination therapy. (September 2015)

3. An international audit of the management of dyslipidaemia and hypertension in patients with rheumatoid arthritis: results from 19 countries. Issue 6 (7th July 2021)

5. Brief recommendations on the management of adult patients with familial hypercholesterolemia during the COVID-19 pandemic. (August 2020)

8. Comparison of the characteristics at diagnosis and treatment of children with heterozygous familial hypercholesterolaemia (FH) from eight European countries. (January 2020)

9. Comparison of the mutation spectrum and association with pre and post treatment lipid measures of children with heterozygous familial hypercholesterolaemia (FH) from eight European countries. (February 2021)

10. Current practice in identifying and treating cardiovascular risk, with a focus on residual risk associated with atherogenic dyslipidaemia. (12th April 2016)